Health Care & Life Sciences » Biotechnology | Port Erin Biopharma Investments Ltd.

Port Erin Biopharma Investments Ltd. | Income Statement

Fiscal year is July-June. All values GBP Thousands.
2013
2014
2015
2016
2017
Sales/Revenue
597.70
2,099.00
190.70
317.80
181.30
Pretax Income
415.20
1,381.50
601.60
534.40
37.00
Consolidated Net Income
415.20
1,381.50
601.60
534.40
37.00
Net Income
415.20
1,381.50
601.60
534.40
37.00
Net Income After Extraordinaries
415.20
1,381.50
601.60
534.40
37.00
Net Income Available to Common
415.20
1,381.50
601.60
534.40
37.00
EPS (Basic)
0.01
0.04
0.02
0.02
0.00
Basic Shares Outstanding
33,196.70
33,864.80
29,626.40
23,195.60
23,195.60
EPS (Diluted)
0.01
0.04
0.02
0.02
0.00
Diluted Shares Outstanding
33,196.70
33,864.80
29,626.40
23,195.60
23,195.60
Total Expense
185.20
621.60
452.20
220.60
228.50
Operating Income
412.50
1,477.50
642.90
538.40
47.10
Non-Operating Income (Expense)
2.70
96.00
41.20
4.10
10.10

About Port Erin Biopharma Investments

View Profile
Address
18 Athol Street
Douglas Isle of Man IM1 1JA
United Kingdom
Employees -
Website http://www.porterinbiopharma.com
Updated 09/14/2018
Port Erin Biopharma Investments Ltd. engages in the investment in the biotechnology and biopharmaceutical sectors. The company was founded on May 3, 2011 and is headquartered in Douglas, Isle of Man. .

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.